ORG Wealth Partners
ARTV icon

ORG Wealth Partners’s Artiva Biotherapeutics ARTV Stock Holding History

ORG Wealth Partners’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21 Buy
+3
New +$30 ﹤0.01% 2525

Other funds holding ARTV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Revelation Capital Management
Revelation Capital Management Sausalito, California $8.01M AUM 49.3% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

ORG Wealth Partners's ARTV Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 3 shares worth $21. The stake represents ﹤0.01% of the portfolio and ranks #2525 among its holdings.

34 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.

  • ORG Wealth Partners held 3 shares of Artiva Biotherapeutics worth $21 as of Q3 2026.
  • Artiva Biotherapeutics was a new ORG Wealth Partners position in Q3 2026.
  • Artiva Biotherapeutics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2525 holding.
  • 34 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.